[V. Minimal invasiveness treatment for young women with ovarian cancer]

Gan To Kagaku Ryoho. 2013 Feb;40(2):182-5.
[Article in Japanese]
No abstract available

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Female
  • Humans
  • Neoplasm Staging
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / therapy*
  • Young Adult

Substances

  • Antineoplastic Agents